Why OpGen Shares Are Trading Higher By 220%? Here Are 64 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• OpGen, Inc. OPGN shares surged 220% to $0.3994 after the company announced topline data from its Unyvero urinary tract infections (UTI) clinical trial.
• Netcapital Inc. NCPL shares jumped 100% to $2.77 following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million.
• Onion Global Limited OG gained 65% to $0.33.
• Jiuzi Holdings, Inc. JZXN shares jumped 46.7% to $0.2171.
• Faraday Future Intelligent Electric Inc. FFIE rose 33.3% to $0.6119 after surging over 55% on Monday. Faraday Future Intelligent Electric recently appointed FF China CEO Xuefeng (XF) Chen as Global CEO of the company
• BeyondSpring Inc. BYSI jumped 31% to $0.9995 after the company presented data with plinabulin for the prevention of docetaxel-induced neutropenia in patients with non-small cell lung cancer and breast cancer at three medical conferences.
• Fluence Energy, Inc. FLNC shares gained 28% to $22.05 after the company reported better-than-expected Q4 sales.
• Shineco, Inc. SISI jumped 27% to $1.6518 after the company announced its subsidary was granted a USPTO patent and FDA marketing approval for its in-situ fecal specimen sampling device.
• Gritstone bio, Inc. GRTS gained 27% to $3.2807. Gritstone bio was granted two new US patents for self-amplifying mRNA.
• Prenetics Global Limited PRE rose 27% to $2.35. Prenetics recently announced a $20 million buyback.
• SenesTech, Inc. SNES gained 26% to $3.13.
• Magenta Therapeutics, Inc. MGTA gained 25.2% to $1.44 after the company highlighted updated data from the ongoing MGTA-117 Phase 1/2 dose-escalation trial at the American Society of Hematology 2022 Annual (ASH) Meeting.
• Grom Social Enterprises, Inc. GROM rose 24.8% to $1.65.
• ClearSign Technologies Corporation CLIR jumped 24.8% to $0.69.
• Moderna, Inc. MRNA surged 22.8% to $202.86 after the company and Merck announced mRNA-4157/V940 in combination with KEYTRUDA, met the primary efficacy endpoint in the Phase 2b KEYNOTE-942 trial.
• Schrödinger, Inc. SDGR rose 22.6% to $20.88.
• Dada Nexus Limited DADA gained 21.7% to $8.02. Shares of Chinese companies traded higher following the recent easing of Covid restrictions in China, which has helped increase travel activity.
• MamaMancini's Holdings, Inc. MMMB rose 21.4% to $1.5308 following better-than-expected Q3 results.
• Ventyx Biosciences, Inc. VTYX rose 21.4% to $34.70 after gaining over 5% on Monday.
• Rallybio Corporation RLYB shares climbed 19.8% to $10.43. JP Morgan, last week, initiated coverage on Rallybio with an Overweight rating and announced a price target of $21.
• ACM Research, Inc. ACMR gained 19.6% to $10.43.
• Wave Life Sciences Ltd. WVE gained 19.4% to $4.3115. Wave Life Sciences and GSK plc have announced a strategic collaboration to advance oligonucleotide therapeutics, including Wave's preclinical RNA editing program targeting alpha-1 antitrypsin deficiency, WVE-006.
• Kaspien Holdings Inc. KSPN rose 19.1% to $0.8799.
• Entrada Therapeutics, Inc. TRDA jumped 18% to $19.16. Vertex Pharmaceuticals and Entrada Therapeutics recently announced a global collaboration focused on discovering and developing intracellular Endosomal Escape Vehicle (EEV) therapeutics for myotonic dystrophy type 1 (DM1).
• Summit Therapeutics Inc. SMMT gained 16.6% to $3.29.
• 180 Life Sciences Corp. ATNF rose 15.5% to $0.3101.
• National Western Life Group, Inc. NWLI gained 14.8% to $277.01.
• 2U, Inc. TWOU gained 14.1% to $7.95.
• Phathom Pharmaceuticals, Inc. PHAT jumped 13.1% to $11.38.
• Ribbon Communications Inc. RBBN surged 12.5% to $2.98.
• Gaotu Techedu Inc. GOTU gained 12% to $1.87. Gaotu Techedu, last month, reported a third-quarter FY22 sales decline of 45.6% year-on-year to RMB606.2 million ($85.21 million).
• Mullen Automotive, Inc. MULN jumped 11.5% to $0.2152 after the company announced it signed its first U.S. dealer partner.
• Pinterest, Inc. PINS climbed 10.6% to $26.12. Piper Sandler upgraded Pinterest from Neutral to Overweight and raised the price target from $25 to $30.
• ARS Pharmaceuticals, Inc. SPRY gained 10.1% to $7.84 after SVB Leerink initiated coverage on the stock with an Outperform rating and a $14 price target.
• Angi Inc. ANGI gained 9.7% to $2.3250 after Citigroup initiated coverage on the stock with a Buy rating and a $2.60 price target.
• Pardes Biosciences, Inc. PRDS rose 9.6% to $1.26. JMP Securities initiated coverage on Pardes Biosciences with a Market Outperform rating and announced a price target of $9.
• MediaCo Holding Inc MDIA rose 5.3% to $1.1485 after the company said it has divested the assets of Fairway Outdoor LLC to Lamar Advertising Company for $78.6 million.
• Oracle Corporation ORCL gained 3% to $83.69 after the company reported better-than-expected results for its second quarter on Monday.

Losers

• Quotient Limited QTNT fell 46% to $0.37. Quotient announced intent to voluntary delist from the Nasdaq Global Market.
• Argo Blockchain plc ARBK shares fell 38.1% to $0.4246. Argo Blockchain recently announced a November operational update..
• Avaya Holdings Corp. AVYA dropped 38% to $0.7149. Avaya disclosed certain information related to ongoing constructive discussions with financial stakeholders.
• Midatech Pharma plc MTP fell 30% to $1.17. Midatech Pharma PLC proposed acquisition of Bioasis Technologies Inc.
• China Jo-Jo Drugstores, Inc. CJJD shares dipped 29% to $5.05 after gaining around 115% on Monday.
• Getaround, Inc. GETR fell 28.8% to $1.46 after dropping 32% on Monday. Getaround recently announced closing of business combination with InterPrivate II Acquisition Corp.
• Edible Garden AG Incorporated EDBL fell 24.4% to $0.3225 after jumping over 59% on Monday.
• Clovis Oncology, Inc. CLVS dropped 24% to $0.1521. Clovis Oncology voluntarily initiated a Chapter 11 proceeding in the U.S. Bankruptcy Court and will seek to sell its assets through a court-supervised sales process.
• Aptevo Therapeutics Inc. APVO fell 23.2% to $3.00. Aptevo Therapeutics shares surged 14% on Monday after the company announced that APVO436, in combination with venetoclax and azacitidine, achieved a 100% clinical benefit rate in venetoclax treatment naïve AML patients.
• Vanda Pharmaceuticals Inc. VNDA dropped 23% to $8.31.
• Hyperfine, Inc. HYPR shares fell 21.9% to $0.9601. Hyperfine, on December 6, committed to organizational restructuring designed to decrease costs, create streamlined organization to support business, and has terminated approximately 13% of its global workforce.
• Corvus Pharmaceuticals, Inc. CRVS dropped 20% to $0.80.
• Harpoon Therapeutics, Inc. HARP dipped 20% to $1.1250. Harpoon Therapeutics recently announced it presented updated interim results at ASH 2022 for novel T cell engager HPN217 in relapsed/refractory multiple myeloma.
• HTG Molecular Diagnostics, Inc. HTGM declined 19.8% to $0.8180.
• Enzo Biochem, Inc. ENZ fell 19.4% to $1.49 following Q1 results.
• Ambrx Biopharma Inc. AMAM shares fell 19.2% to $2.3099 after dipping 37% on Monday.
• Adamas One Corp. JEWL shares fell 17.3% to $3.9250.
• Curis, Inc. CRIS fell 17% to $0.5399. Curis shares announced additional clinical data from the TakeAim Leukemia study of emavusertib.
• Bone Biologics Corporation BBLG dropped 16.8% to $0.2446.
• SeqLL Inc. SQL fell 16.2% to $0.44.
• The Lion Electric Company LEV fell 14.5% to $2.2810. Lion Electric reported pricing of 19,685,040 unit offering at $2.54 per unit.
• Aerovate Therapeutics, Inc. AVTE fell 11.5% to $27.00. Aerovate Therapeutics, last month, posted a Q3 loss of $0.56 per share.
• Nikola Corporation NKLA fell 11.5% to $2.0699.
• Silvergate Capital Corporation SI dropped 11.5% to $18.80. JP Morgan maintained Silvergate Capital with an Overweight and lowered the price target from $50 to $30.
• Engine Gaming and Media, Inc. GAME fell 9.3% to $0.9584 after jumping 95% on Monday. The company last Thursday announced it has entered into an agreement to combine with GameSquare Esports.
• JetBlue Airways Corporation JBLU fell 8.6% to $7.03 as the company said it expects Q4 revenue per ASM at the low end of its guidance range.

Also check this out Ethereum Jumps Above This Major Level; Toncoin Emerges As Top Gainer.